Jason Carney: Challenging Long-Standing Assumptions About Women and Anemia
Jason Carney, Senior Vice President, Clinical Strategist at hc1, shared Tiffany Hall‘s post on LinkedIn:
“Important data and an important conversation. The evidence challenges a long-standing assumption about women and anemia—and shows why we need to design clinical thresholds around patient outcomes, not population averages.
At hc1, we’re focused on translating insights like these into practical, consistent clinical decision support that helps close gaps at the point of care.
Proud of Tiffany Hall and the team advancing this work and the impact it can have on safer, more equitable patient care.”
Tiffany Hall, Director of cPBM Clinical Technology at hc1, shared a post on LinkedIn about a recent article by Florian Rumpf et al. published in Frontiers in Medicine, adding:
“A landmark 842,130-patient study exposed a flaw in how we diagnose anemia in women before surgery.
Many Pre-Surgical Testing clinics follow the current WHO guidelines which let women’s hemoglobin fall lower than men’s before anemia is even flagged (less than 12 g/dL for women vs. less than 13 g/dL for men). It’s been standard practice for decades.
But new outcomes data from Rumpf F, Hof L, Old O, et al. tells a different story. Across 14 hospitals and a decade of surgical cases, researchers found the hemoglobin level that actually predicts in-hospital mortality equally for men and women is 10.5 g/dL. Below that point, women don’t tolerate low hemoglobin better than men, they face higher mortality risk at the same level.
Why?
Women also carry less circulating blood volume. Below 10.5 g/dL, that combination leaves zero physiological reserve to absorb surgical blood loss, directly driving the mortality gap this study uncovered.
This isn’t a case of women needing a different standard. It’s a case of the current standard never being built on survival risk in the first place.
hc1 ClinicalIQ‘s anemia management module closes this gap at the source. This EHR-integrated solution automates the diagnostic threshold to a single 13 g/dL trigger for every patient, no sex-based split, no manual chart review, no missed flags. One threshold, applied consistently, well above the point where the survival gap emerges.”
Title: Preoperative hemoglobin thresholds for survival equity in women and men
Authors: Florian Rumpf, Lotta Hof, Oliver Old, Patrick Friederich, Jens Friedrich, Josef Thoma, Maria Wittmann, Kai Zacharowski, Suma Choorapoikayil, and Patrick Meybohm

Stay updatedon all scietific advances with Hemostasis Today.
-
Aug 28, 2026, 19:01Aseemita Debata: First Trimester – Common Problems and Possible Complications
-
Aug 28, 2026, 17:16ASH 2026 Guideline on ITP: Evolving Treatment Strategies
-
Aug 28, 2026, 16:44HEMGENIX Supply Update for the Hemophilia B Community – National Bleeding Disorders Foundation
-
Aug 28, 2026, 16:39Maria Elisa Mancuso: Attending EHC 2026 Annual Conference in Istanbul
-
Aug 28, 2026, 16:25Manali Kakadia: Evaluation and Management of Recurrent Epistaxis
-
Aug 28, 2026, 16:18Navigating Higher Education with a Bleeding Disorder – Bleeding Disorders Council of California
-
Aug 28, 2026, 16:11Maia Meier: Reaching New Heights for Women With Inherited Bleeding Disorders
-
Aug 28, 2026, 15:10Ify Osunkwo: Strengthening Sickle Cell Care Systems at Global Conference in Nairobi
-
Aug 28, 2026, 15:08Muhammed Safvan: One Drop of Blood Can Tell a Story